Georges Rawadi

Health Technology

Consumer Services

Profile

Georges Rawadi served as the Chief Executive Officer and Executive Director at Celyad Oncology SA in 2023 and as the Chief Executive Officer and Director at YSOPIA Biosciences SA from 2018 to 2021.
Prior to that, he was the Vice President of Business Development at Celyad Oncology SA from 2014 to 2018 and held the same position at Cellectis SA. Rawadi holds a doctorate from Université Pierre et Marie Curie and a graduate degree from ESSEC Business School.

Former positions of Georges Rawadi

Companies	Position	End
CELYAD ONCOLOGY SA	Chief Executive Officer	30/11/2023
YSOPIA Biosciences SA YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France.	Chief Executive Officer	31/08/2021
CELYAD ONCOLOGY SA	Corporate Officer/Principal	22/03/2018
CELLECTIS S.A.	Corporate Officer/Principal	-

See the detail of Georges Rawadi's experience

Training of Georges Rawadi

ESSEC Business School

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Georges Rawadi's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
CELYAD ONCOLOGY SA	Health Technology
CELLECTIS S.A.	Health Technology

Private companies	2
Université Pierre et Marie Curie	Consumer Services
YSOPIA Biosciences SA YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France.	Health Technology